Results
It was revealed that applying a complex of peptide medications in treating patients with fast ovarian aging
in the 2nd group helped improve general health. Laboratory and instrumental indicators also improved.
Considering the results of our study, we can say that our complex of peptides has a regulatory effect
on hormonal function and ovarian functional reserve. This complex also caused the positive changes in
ovaries, detected by ultrasonography.
Efficiency of a complex of peptides (Endoluten and Zhenoluten) in case Table 1
of fast ovarian aging
Indicators Follicular Norm Group 1 Before Group 1 Placebo Group 2 Before Group 2 Peptides
phase treatment 4 months later treatment 4 months later
Number of patients 62 62 214 214
USG 10-25 follicles 7-8 / 7-8 8-9 / 7-8 7-8 / 7-8 + *
Increase in the for each ovary 11-12 / 10-11
number of antral (98 % cases)
follicles (left / right)
FSH 1.4-9.9 mIU/lv 6.38±0.42 5.71±0.29 6.24±0.31 4.96±0.29
Estradiol 68-1269 183.14±16.92 209.26±12.64 194.16±11.57 616.24±69.42 *
pmoI/l
AMH 1.00-12.6 0.74±0.12 0.82±0.24 0.76±0.13 1.16±0.18 *
ng/ml (68 % cases)
Onset No data - 8 % - 71 %
of pregnancy
* — reliable, compared with the group 1; + — positive changes; USG — ultrasonography; FSH — follicle-stimulating hor
mone; AMH — anti-Mullerian hormone.
Comparative analysis of the application of peptide medications in case of fast ovarian aging shows that it
is preferable to apply this complex of peptides containing ovarian and pineal gland peptides as a pregnan
cy medication program and as a part of a complex treatment instead of hormonal therapy. These drugs
have no side effects, do not cause complications or addiction. There are no medical contraindications to
their use. We also recommend this complex to maintain the neuroendocrine and reproductive system
functions to prevent metabolic disorders in middle and senior age.
Recommended dosages:
Zhenoluten — 2 capsules per day for 4 months.
Endoluten — 1 capsule per day (in the morning) for 4 months.
It is advisable to repeat courses of treatment every 6 months.
Conclusion
Based on the data obtained during the study, we can conclude that existing conventional treatment reg
imens of fast ovarian aging require revision and a new approach. The new method involves the inclusion
of these high-performance schemes, which use physiological peptide drugs with targeted action aimed
at increasing the reserve capacity of the organs and tissues involved in the pathological processes.
Gothenburg, Sweden 2019
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.